{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:48:20Z","timestamp":1788536900061,"version":"build-2803163510"},"reference-count":148,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.modpat.2024.100441","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T01:05:01Z","timestamp":1706835901000},"page":"100441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-8006","authenticated-orcid":false,"given":"L. Jeffrey","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Chadburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikkeri N.","family":"Naresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.modpat.2024.100441_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib2","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1080\/10428194.2022.2092857","article-title":"Monoclonal B-cell lymphocytosis \u2013 a review of diagnostic criteria, biology, natural history, and clinical management","volume":"63","author":"Tang","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib3","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3324\/haematol.2011.042333","article-title":"Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis","volume":"96","author":"Gibson","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1309\/AJCPPHSUQM8XBJH7","article-title":"Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns","volume":"139","author":"Randen","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"25","key":"10.1016\/j.modpat.2024.100441_bib5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100441_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","article-title":"Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\u201caccelerated\u201d chronic lymphocytic leukemia) with aggressive clinical behavior","volume":"95","author":"Gin\u00e9","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.modpat.2024.100441_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.humpath.2018.07.030","article-title":"Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption","volume":"82","author":"Garces","year":"2018","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100441_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.modpat.2024.100441_bib10","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1815281","article-title":"Venetoclax and obinutuzumab in patients with CLL and coexisting conditions","volume":"380","author":"Fischer","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.modpat.2024.100441_bib11","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1812836","article-title":"Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL","volume":"379","author":"Woyach","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.modpat.2024.100441_bib12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.2019003453","article-title":"International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia","volume":"135","author":"Condoluci","year":"2020","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.modpat.2024.100441_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1200\/JCO.2016.70.2282","article-title":"BTK-mediated resistance to ibrutinib in chronic lymphocytic leukemia","volume":"35","author":"Woyach","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.modpat.2024.100441_bib14","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.2019003722","article-title":"Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK\/PLCG2 mutations","volume":"135","author":"Lucas","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib15","first-page":"339","article-title":"Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal","volume":"12","author":"Melo","year":"1987","journal-title":"Blood Cells"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1309\/PPK0-TJUK-1UAR-3194","article-title":"Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma","volume":"115","author":"Schlette","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100441_bib17","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.humpath.2012.01.003","article-title":"Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation","volume":"43","year":"2012","journal-title":"Hum Pathol"},{"issue":"21","key":"10.1016\/j.modpat.2024.100441_bib18","first-page":"1821","article-title":"Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53","volume":"134","author":"Chapiro","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2024.100441_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151790","article-title":"B-prolymphocytic leukemia: is it time to retire this entity?","volume":"54","author":"El Hussein","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.modpat.2024.100441_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.152003","article-title":"Sunsetting B-prolymphocytic leukemia","volume":"60","author":"Abdulbaki","year":"2022","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41375-023-01872-6","article-title":"Response to the comments from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors","volume":"37","author":"Siebert","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/cancers14030697","article-title":"The genomics of hairy cell leukaemia and splenic diffuse red pulp lymphoma","volume":"14","author":"Oscier","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3109\/10428194.2015.1096357","article-title":"Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression","volume":"57","author":"Cao","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.modpat.2024.100441_bib24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ajh.25600","article-title":"Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network","volume":"94","author":"Varettoni","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.modpat.2024.100441_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2022.10.005","article-title":"Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms","volume":"130","author":"Qiu","year":"2022","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","article-title":"Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin","volume":"480","author":"Vela","year":"2022","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.modpat.2024.100441_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib28","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","article-title":"Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times","volume":"156","author":"Wahlin","year":"2012","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib30","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.3324\/haematol.2017.175059","article-title":"Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort","volume":"103","author":"Rimsza","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjh.18404","article-title":"The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment","volume":"199","author":"Naik","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-023-00462-z","article-title":"Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study","volume":"11","author":"Zha","year":"2023","journal-title":"Biomark Res"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cancers15030785","article-title":"Follicular lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Biological Data","volume":"15","author":"Kurz","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.modpat.2024.100441_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2017.11.002","article-title":"Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma","volume":"72","author":"El Behery","year":"2018","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100441_bib35","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","article-title":"High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B","volume":"45","author":"Laurent","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib36","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/modpathol.2012.117","article-title":"Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues","volume":"25","author":"Adam","year":"2012","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100441_bib37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1309\/JQMR-323G-71Y9-M7MB","article-title":"Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities","volume":"116","author":"Onciu","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib39","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib40","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(\u2212) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2024.100441_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"hijack immunoglobulin light-chain enhancers in cyclin D1 mantle cell lymphoma","volume":"133","author":"Mart\u00edn-Garcia","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/modpathol.2017.135","article-title":"CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course","volume":"31","author":"Hu","year":"2018","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100441_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11912-021-01094-y","article-title":"Leukemic variant of mantle cell lymphoma: clinical presentation and management","volume":"23","author":"Isaac","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib45","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib46","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib47","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/cancers15082285","article-title":"Large B-cell lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts","volume":"15","author":"Kurz","year":"2023","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.modpat.2024.100441_bib48","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1182\/blood-2010-03-276766","article-title":"Immunoblastic morphology but not the immunohistochemical GCB\/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL","volume":"116","author":"Ott","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41408-023-00827-5","article-title":"A\u00a0retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications","volume":"13","author":"El-Sharkawi","year":"2023","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib50","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1016\/j.modpat.2024.100441_bib52","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a haematological malignancy research network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/nan.12259","article-title":"Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas","volume":"42","author":"Nakamura","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.blre.2017.12.001","article-title":"The pathobiology of primary testicular diffuse large B-cell lymphoma: implications for novel therapies","volume":"32","author":"Twa","year":"2018","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00428-019-02698-3","article-title":"Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis","volume":"476","author":"King","year":"2020","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-021-00493-5","article-title":"Genomic insights into the pathogenesis of Epstein\u2013Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing","volume":"11","author":"Gebauer","year":"2021","journal-title":"Blood Cancer J"},{"issue":"11","key":"10.1016\/j.modpat.2024.100441_bib57","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/bloodadvances.2020001923","article-title":"Gene expression profiling of gray zone lymphoma","volume":"4","author":"Sarkozy","year":"2020","journal-title":"Blood Adv"},{"issue":"13","key":"10.1016\/j.modpat.2024.100441_bib58","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational landscape of gray zone lymphoma","volume":"137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.modpat.2024.100441_bib59","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/PAS.0b013e3182515fb5","article-title":"Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation?","volume":"36","author":"Boroumand","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PAS.0000000000000775","article-title":"Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation","volume":"41","author":"Boyer","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100441_bib61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-023-03599-2","article-title":"Cavity-based lymphomas: challenges and novel concepts","volume":"483","author":"Di Napoli","year":"2023","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib62","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41379-021-00863-1","article-title":"Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship","volume":"34","author":"Medeiros","year":"2021","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib63","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/PAS.0000000000001168","article-title":"Age and CD20 Expression are significant prognostic factors in human herpes virus-8-negative effusion-based lymphoma","volume":"42","author":"Kubota","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib64","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/cancers13040878","article-title":"Primary effusion lymphoma: a clinicopathological study of 70 cases","volume":"13","author":"Hu","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/diagnostics12030713","article-title":"Primary ffusion lymphoma: a timely review on the association with HIV, HHV8, and EBV","volume":"12","author":"Liu","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"10.1016\/j.modpat.2024.100441_bib66","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3324\/haematol.2016.151647","article-title":"Genetic background and evolution of relapses in aggressive B-cell lymphomas","volume":"102","author":"Juskevicius","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.modpat.2024.100441_bib67","doi-asserted-by":"crossref","DOI":"10.1053\/j.seminhematol.2023.11.002","article-title":"DLBCL arising from indolent lymphomas: how are they different?","author":"Parry","year":"2023","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib68","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000561","article-title":"High-grade transformation of low-grade B-cell lymphoma: pathology and molecular pathogenesis","volume":"40","author":"Agbay","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib70","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajh.26068","article-title":"First-line treatment of double-hit and triple-hit lymphomas: survival and tolerance data from a retrospective multicenter French study","volume":"96","author":"Laude","year":"2021","journal-title":"Am J Hematol"},{"issue":"20","key":"10.1016\/j.modpat.2024.100441_bib71","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","article-title":"High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology","volume":"2","author":"Chong","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib72","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","article-title":"Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-022-03404-6","article-title":"Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma","volume":"482","author":"King","year":"2023","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib74","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100441_bib75","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/his.12884","article-title":"MYC\/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis","volume":"68","author":"Li","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41379-018-0112-9","article-title":"High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma","volume":"32","author":"Ok","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PAS.0000000000001750","article-title":"Mutational landscape of TdT+ large B-cell lymphomas supports their distinction from B-lymphoblastic neoplasms: a multiparameter study of a rare and aggressive entity","volume":"46","author":"Bhavsar","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib78","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib79","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100441_bib80","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib81","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000001869","article-title":"Burkitt-like lymphoma with 11q aberration: a characteristic chromosomal alteration and a particular morphologic feature","volume":"46","author":"Horn","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100441_bib82","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1182\/bloodadvances.2023009731","article-title":"High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study","volume":"7","author":"Zayac","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib83","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41375-022-01778-9","article-title":"High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL\/HGBL-DH than DLBCL","volume":"37","author":"Li","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib84","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00000478-200303000-00002","article-title":"Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders","volume":"27","author":"Nador","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajcp\/aqw200","article-title":"Immunodeficiency and dysregulation: report of the 2015 Workshop of the Society for Hematopathology\/European Association for Haematopathology","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"18","key":"10.1016\/j.modpat.2024.100441_bib86","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","article-title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","volume":"132","author":"Natkunam","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3960\/jslrt.19007","article-title":"Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"59","author":"Tokuhira","year":"2019","journal-title":"J\u00a0Clin Exp Hematop"},{"issue":"18","key":"10.1016\/j.modpat.2024.100441_bib88","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.modpat.2024.100441_bib89","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/PAS.0000000000001113","article-title":"Expanding the spectrum of EBV-positive marginal zone lymphomas: a lesion associated with diverse immunodeficiency settings","volume":"42","author":"Gong","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAS.0000000000000954","article-title":"Cancer therapy-associated lymphoproliferative disorders: an under-recognized type of immunodeficiency-associated lymphoproliferative disorder","volume":"42","author":"Pina-Oviedo","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41379-019-0365-y","article-title":"KSHV\/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap","volume":"33","author":"Vega","year":"2020","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100441_bib92","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.2020005470","article-title":"KSHV\/HHV8-mediated hematologic diseases","volume":"139","author":"Cesarman","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","article-title":"Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders","volume":"85","author":"Knowles","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib94","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12885-021-08215-7","article-title":"Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence","volume":"21","author":"Zanelli","year":"2021","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2024.100441_bib95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.prp.2007.03.002","article-title":"Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients","volume":"203","author":"Kojima","year":"2007","journal-title":"Pathol Res Pract"},{"issue":"6","key":"10.1016\/j.modpat.2024.100441_bib96","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0046-8177(89)90247-5","article-title":"Progressive lymph node histology and its prognostic value in patients with acquired immunodeficiency syndrome and AIDS-related complex","volume":"20","author":"Chadburn","year":"1989","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.semdp.2017.11.015","article-title":"Autoimmune and medication-induced lymphadenopathies","volume":"35","author":"Gru","year":"2018","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib98","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-positive B-cell proliferations of varied malignant potential: 2015 SH\/EAHP Workshop Report-Part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib99","first-page":"173","article-title":"The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression","volume":"133","author":"Nalesnik","year":"1988","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100441_bib100","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/1097-0142(19950601)75:11<2747::AID-CNCR2820751119>3.0.CO;2-3","article-title":"Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms","volume":"75","author":"Chadburn","year":"1995","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib101","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ajcp\/aqw216","article-title":"B-cell and classical Hodgkin lymphomas associated with immunodeficiency: 2015 SH\/EAHP Workshop Report-Part 2","volume":"147","author":"de Jong","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ajcp\/aqw218","article-title":"HHV8\/KSHV-positive lymphoproliferative disorders and the spectrum of plasmablastic and plasma cell neoplasms: 2015 SH\/EAHP Workshop Report-Part 3","volume":"147","author":"Chadburn","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"16","key":"10.1016\/j.modpat.2024.100441_bib103","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era","volume":"105","author":"Gopal","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib104","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcp\/aqw215","article-title":"Primary\/congenital immunodeficiency: 2015 SH\/EAHP Workshop Report-Part 5","volume":"147","author":"Gratzinger","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.path.2019.03.003","article-title":"Castleman disease","volume":"12","author":"Wang","year":"2019","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib106","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease","volume":"7","author":"Carbone","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.modpat.2024.100441_bib107","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00277-020-04024-3","article-title":"Germinotropic lymphoproliferative disorder: a systematic review","volume":"99","author":"Zanelli","year":"2020","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin\u2019s lymphoma","volume":"9","author":"K\u00fcppers","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib109","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and Reed\u2013Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pathol.2019.09.005","article-title":"Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis","volume":"52","author":"Piris","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.modpat.2024.100441_bib111","article-title":"Incidence patterns and outcomes for hodgkin lymphoma patients in the United States","volume":"2011","author":"Shenoy","year":"2011","journal-title":"Adv Hematol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib112","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.modpat.2024.100441_bib113","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.modpat.2024.100441_bib114","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/v5061587","article-title":"NF-\u03baB and IRF7 pathway activation by Epstein\u2013Barr virus latent membrane protein 1","volume":"5","author":"Ersing","year":"2013","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.modpat.2024.100441_bib115","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3390\/cancers15072133","article-title":"EBV and lymphomagenesis","volume":"15","author":"Sausen","year":"2023","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.modpat.2024.100441_bib116","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib117","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J\u00a0Exp Med"},{"issue":"7338","key":"10.1016\/j.modpat.2024.100441_bib118","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.modpat.2024.100441_bib119","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed\u2013Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00428-023-03554-1","article-title":"The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology","volume":"483","author":"Hartmann","year":"2023","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.modpat.2024.100441_bib121","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bjh.14861","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data","volume":"182","author":"Shivarov","year":"2018","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.modpat.2024.100441_bib122","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1080\/10428194.2019.1639166","article-title":"Clinical features and survival of patients with T-cell\/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base","volume":"60","author":"Ollila","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib123","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3324\/haematol.2018.203224","article-title":"JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma","volume":"104","author":"Schuhmacher","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib124","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","article-title":"Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"11","author":"Thurner","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib125","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3324\/haematol.2023.282698","article-title":"B-cell receptor reactivity against in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"108","author":"Thurner","year":"2023","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.modpat.2024.100441_bib126","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib127","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bjh.14518","article-title":"Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups","volume":"177","author":"Shankar","year":"2017","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1016\/j.modpat.2024.100441_bib128","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib129","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/s41375-020-0739-7","article-title":"Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma","volume":"34","author":"Song","year":"2020","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.modpat.2024.100441_bib130","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMra2033982","article-title":"Autoimmune hemolytic anemias","volume":"385","author":"Berentsen","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.modpat.2024.100441_bib131","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2016.146126","article-title":"Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity","volume":"101","author":"Ma\u0142ecka","year":"2016","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.modpat.2024.100441_bib132","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/bloodadvances.2020001608","article-title":"Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18","volume":"4","author":"Ma\u0142ecka","year":"2020","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.modpat.2024.100441_bib133","doi-asserted-by":"crossref","first-page":"E279","DOI":"10.1002\/ajh.26205","article-title":"The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels","volume":"96","author":"Ma\u0142ecka","year":"2021","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib134","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ajcp\/aqad048","article-title":"The histopathology of cold agglutinin disease-associated B-cell lymphoproliferative disease","volume":"160","author":"Guenther","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2024.100441_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.modpat.2024.100441_bib136","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited: a multinational, observational study of 232 patients","volume":"136","author":"Berentsen","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib137","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.kint.2020.07.037","article-title":"Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants","volume":"99","author":"Nasr","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.modpat.2024.100441_bib138","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.modpat.2024.100441_bib139","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib140","first-page":"472","article-title":"A\u00a0modern primer on light chain amyloidosis in 592 patients with mass spectrometry-verified typing","volume":"94","author":"Muchtar","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"20","key":"10.1016\/j.modpat.2024.100441_bib141","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.modpat.2024.100441_bib142","first-page":"25","article-title":"Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome","volume":"5","author":"Farooq","year":"2012","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100441_bib143","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00005792-200301000-00005","article-title":"The AESOP (adenopathy and extensive skin patch overlying a plasmacytoma) syndrome: report of 4 cases of a new syndrome revealing POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome at a curable stage","volume":"82","author":"Lipsker","year":"2003","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.modpat.2024.100441_bib144","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.modpat.2024.100441_bib145","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100441_bib146","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2013.247","article-title":"IMWG consensus on risk stratification in multiple myeloma","volume":"28","author":"Chng","year":"2014","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.modpat.2024.100441_bib147","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2024.100441_bib148","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41408-021-00587-0","article-title":"Primary plasma cell leukemia: consensus definition by the International Myeloma Working\u00a0Group according to peripheral blood plasma cell percentage","volume":"11","author":"Fern\u00e1ndez de Larrea","year":"2021","journal-title":"Blood Cancer J"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224000218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224000218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:22:57Z","timestamp":1744248177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224000218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0893395224000218"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100441","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100441"}}